Pharma

Pharma

Interim data from tenapanor’s OPTIMIZE trial signals promising treatment option for CKD-HP, says GlobalData

Ardelyx presented interim data from its ongoing OPTIMIZE study at the European Renal Association. The primary endpoint of the Phase IV OPTIMIZE study is to evaluate the use of tenapanor as the main therapy option for chronic kidney disease (CKD)–hyperphosphatemia (HP) patients on dialysis. Tenapanor is expected to gain a front-line position in the CKD […]

Pharma

Covid-19 infection prevention methods should be strictly adhered to during the Tokyo Olympic Games, says GlobalData

The Olympic games are considered to be the world’s most prestigious sports competition, with more than 200 nations participating. However, this year’s Olympic games are facing complications due to the global COVID-19 pandemic. In order to limit the potential outbreak of hosting the event, spectators as well as athletes and support staff should entirely avoid […]

Pharma

UniQure’s AMT-130 joins the tough race to cure Huntington’s disease, says GlobalData

UniQure recently announced the enrolment of the first two patients in the second cohort of a Phase I/II clinical trial of AMT-130, a micro ribonucleic acid (miRNA) gene therapy, in development for Huntington’s disease (HD). Considering the pressing need for a DMT and the limited pipeline candidates, AMT-130 will have a great opportunity to become […]

Pharma

Immediate action is necessary to tackle exponential rise in COVID-19 due to Delta variant in UK, says GlobalData

Following the news that cases of COVID-19 due to the Delta variant in the UK have increased, despite record numbers of people being vaccinated; Emily Martyn, Infectious Disease Analyst at GlobalData, a leading data and analytics company, offers her view: “While the UK Vaccine Taskforce should be applauded for its sterling work in ensuring 83.3%* […]

Pharma

Keytruda may have won the battle of European approval in metastatic esophageal cancer against Opdivo, but the war will be judged in the adjuvant setting, says GlobalData

Following today’s news (29 June) that Merck & Co’s Keytruda received EMA approval for patients with esophageal cancer (EC) or HER2-negative gastroesophageal junction (GEJ) adenocarcinoma with PD-L1 combined positive score (CPS ≥10); Sakis Paliouras, PhD, Senior Oncology & Hematology Analyst at GlobalData, a leading data, and analytics company, offers his view: “When combined with chemotherapy, […]

Pharma

Teplizumab’s approval will be paradigm changing for T1D as first disease-modifying therapeutic, says GlobalData

The Food and Drug Administration (FDA)’s Endocrinologic and Metabolic Drugs Advisory Committee voted in favor of Provention Bio’s teplizumab 10-7 to delay the onset of type 1 diabetes (T1D). In the eight major markets (8MM*) the number of diagnosed prevalent cases of T1D will grow at an annual growth rate (AGR) of 1.78%, from 3.3 […]

Pharma

Overactive Bladder market characterized by significant untapped potential, says GlobalData

Untapped potential within the overactive bladder (OAB) market remains considerable due to under-diagnosis and under-treatment of this highly prevalent condition, according to GlobalData, a leading data and analytics company. Key opinion leaders (KOLs) interviewed by GlobalData verified that only a minority of patients with OAB, a symptom complex characterized by urinary urgency, with or without […]

Pharma

Diagnosed prevalent cases of uveitis to reach 1.9 million by 2029 in the 9MM, says GlobalData

The diagnosed prevalent cases of uveitis in the nine major markets (*9MM) are projected to increase from 1.7 million cases in 2019 to 1.9 million cases in 2029, equating to an annual growth rate (AGR) of 0.97%, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Uveitis – Epidemiology Forecast to 2029’, […]

Pharma

Tokyo Olympics could be an epicenter for new COVID-19 infections, says GlobalData

The Tokyo Olympics will likely be an epicenter of transmission for COVID-19 and could increase variant of concern (VOC) spread, bringing new cases to Japan and new cases back to home countries, says GlobalData, a leading data and analytics company. According to GlobalData, there have been over 94 million new cases of COVID-19 in 2021 […]

Pharma

Rapid-acting Sage Therapeutics and Biogen’s zuranolone could alter way depression is treated, says GlobalData

Sage Therapeutics and Biogen have recently announced positive results from a pivotal Phase III trial for their novel, GABA A receptor allosteric modulator, antidepressant zuranolone. Zuranolone could alter the way major depressive disorder (MDD) is treated with a focus on episodic treatment instead of maintenance treatment, says GlobalData, a leading data and analytics company. Philippa […]

Pharma

Patient access to gene therapies for cancer set to increase over the next decade, says GlobalData

Gene therapies will provide a valid treatment option for patients that have developed resistance to chemotherapies across several cancer indications. With patient access set to increase over the next decade, these therapies are expected to eliminate the need for further treatments and reduce the cost of disease management, says GlobalData, a leading data and analytics […]

Pharma

Fabry disease market growth in US and Japan will be driven by entrance of several novel therapies

The Fabry disease (FD) market in the US and Japan will see significant growth between 2020 and 2030, as total sales in these two major markets (2MM) are set to increase from $820.15m in 2020 to $985.81m in 2030, at a compound annual growth rate (CAGR) of 1.9%. This sales growth will be in line […]

Pharma

Bio-Thera golimumab biosimilar better positioned to get first to market advantage in China and Europe, says GlobalData

China’s Bio-Thera Solutions has recently initiated a Phase III trial of its proposed golimumab biosimilar BAT2506 in China and Eastern Europe. Against this backdrop, BAT2506 is the first subcutaneous golimumab biosimilar to enter a Phase III trial in multiple countries. It has the potential to be the first golimumab biosimilar to gain approval in China […]

Pharma

Novavax’s COVID-19 vaccine may face severe uptake challenges in the US

Novavax has further demonstrated excellent results from its pivotal PREVENT-19 vaccine trial. Despite this positive data, it will likely see very little uptake in the US, says GlobalData, a leading data and analytics company. Nancy Jaser, PharmD/MBA, Pharma Analyst at GlobalData, comments: “Novavax’s PREVENT-19 trial enrolled close to 30,000 participants across 119 sites in the […]

Pharma

China biopharma firms eye partnerships with western counterparts to promote indigenous drugs, says GlobalData

Chinese biopharma companies are eyeing strategic collaborations with western counterparts to leverage their extensive networks and commercial capabilities to promote indigenously developed drugs in China, says GlobalData, a leading data and analytics company. China-based Luye Pharma Group’s holding subsidiary Boan Biotech signed an agreement with AstraZeneca China in May 2021 regarding the promotion rights to […]

Pharma

New product launches to propel systemic sclerosis market to $1.8bn by 2030

The systemic sclerosis (SSc) market is expected to grow from $498m in 2020 to $1.8bn in 2030 across the seven major markets (7MM*) at a strong compound annual growth rate (CAGR) of 14%, according to GlobalData, a leading data and analytics company. The company’s latest report, ‘Systemic Sclerosis: Global Drug Forecast and Market Analysis to […]

Pharma

CARsgen’s novel pipeline therapy could be beneficial to underserved patients in late-stage advanced HCC, says GlobalData

CARsgen Therapeutics’ novel pipeline therapy for advanced hepatocellular carcinoma (HCC) stands out in the American Society of Clinical Oncology (ASCO) virtual annual meeting for being the first-in-class approach with a unique mechanism of action that targets heavily pretreated advanced HCC patients, says GlobalData, a leading data and analytics company. Results for multiple HCC clinical trials […]

Pharma

AstraZeneca, Pfizer, Roche lead non-small cell lung cancer digital marketing space in Japan, finds GlobalData

The non-small cell lung cancer (NSCLC) treatment landscape in Japan looks very mature with multiple drugs approved for targeted therapy, immunotherapy and chemotherapy. In this well-established market, several companies are active on digital channels to support NSCLC patients, amongst which AstraZeneca, Pfizer and Roche are the leaders, observes GlobalData, a leading data and analytics company. […]

Pharma

Latest patent reforms to further bolster innovative pharma research in China, says GlobalData

China has made its latest patent amendments effective from June 01, 2021, reforms which are likely to ensure protection against untimely and unfair generic competition. As a result, the Chinese pharmaceutical market makes itself further competitive and conducive for innovative research companies, both regional and international, says GlobalData, a leading data and analytics company. Although […]

Pharma

Global oncology Phase II clinical trials heavily impacted by COVID-19 disruptions, says GlobalData

Companies and organizations continue to report clinical trial disruptions across the globe due to the COVID-19 pandemic. These disruptions are being caused by a number of factors including delayed initiation, enrollment suspension, and slow enrollment, according to GlobalData, a leading data and analytics company. GlobalData’s recent global survey of key opinion leaders in the pharma […]

Prev 1 … 60 61 62 63 64 … 108 Next

Interim data from tenapanor’s OPTIMIZE trial signals promising treatment option for CKD-HP, says GlobalData

Covid-19 infection prevention methods should be strictly adhered to during the Tokyo Olympic Games, says GlobalData

UniQure’s AMT-130 joins the tough race to cure Huntington’s disease, says GlobalData

Immediate action is necessary to tackle exponential rise in COVID-19 due to Delta variant in UK, says GlobalData

Keytruda may have won the battle of European approval in metastatic esophageal cancer against Opdivo, but the war will be judged in the adjuvant setting, says GlobalData

Teplizumab’s approval will be paradigm changing for T1D as first disease-modifying therapeutic, says GlobalData

Overactive Bladder market characterized by significant untapped potential, says GlobalData

Diagnosed prevalent cases of uveitis to reach 1.9 million by 2029 in the 9MM, says GlobalData

Tokyo Olympics could be an epicenter for new COVID-19 infections, says GlobalData

Rapid-acting Sage Therapeutics and Biogen’s zuranolone could alter way depression is treated, says GlobalData

Patient access to gene therapies for cancer set to increase over the next decade, says GlobalData

Fabry disease market growth in US and Japan will be driven by entrance of several novel therapies

Bio-Thera golimumab biosimilar better positioned to get first to market advantage in China and Europe, says GlobalData

Novavax’s COVID-19 vaccine may face severe uptake challenges in the US

China biopharma firms eye partnerships with western counterparts to promote indigenous drugs, says GlobalData

New product launches to propel systemic sclerosis market to $1.8bn by 2030

CARsgen’s novel pipeline therapy could be beneficial to underserved patients in late-stage advanced HCC, says GlobalData

AstraZeneca, Pfizer, Roche lead non-small cell lung cancer digital marketing space in Japan, finds GlobalData

Latest patent reforms to further bolster innovative pharma research in China, says GlobalData

Global oncology Phase II clinical trials heavily impacted by COVID-19 disruptions, says GlobalData

Browse

Company information